American Melanoma Institute · 5 min read
What trial phases mean, how randomization and placebos are used in cancer studies, your rights as a participant, what insurance covers, and where to search.
Every drug now used for advanced melanoma reached patients through clinical trials. A trial is a research study that tests a treatment in people under a written plan called a protocol. Trials exist for every stage of skin cancer, and a trial can be weighed alongside standard treatment at any point in care.
The phase tells you what question the study is asking.
An early-phase trial carries more unknowns and may offer access to a drug years before approval. In a phase 3 trial, you may be assigned to the standard treatment.
In a randomized trial, a computer assigns each participant to a group by chance. Neither you nor your doctor picks. The National Cancer Institute explains that this prevents bias, such as doctors steering healthier patients toward the new treatment, and makes the comparison fair.
Many people fear being given a sugar pill in place of cancer treatment. The American Cancer Society states that most cancer trials do not use placebos unless they are given along with standard treatment, because withholding a treatment known to work would be unethical. The usual comparison is the best current treatment.
A placebo alone is used only when the standard of care is no treatment at all. KEYNOTE-716 is an example. When it began, the standard after surgery for stage IIB and IIC melanoma was observation, so the comparison group received a placebo infusion and the same close follow-up. The consent form always states whether a placebo is part of the study.
Before you join, the research team must explain the purpose of the study, every procedure, and the possible risks and benefits, in language you understand. This process is called informed consent. You receive the information in writing and can ask as many questions as you need.
Signing the form does not bind you. You can leave a trial at any time, for any reason, and return to standard care with your regular doctors. The team must also tell you about new findings that could affect your decision to stay.
Oversight comes in 2 layers. An institutional review board (IRB), which includes people from outside the research team, must approve the study and reviews it at least yearly. Many trials also have a data and safety monitoring board, a group of independent experts who look at results as they come in. That board can stop a trial early for safety reasons or because the answer is already clear. The DREAMseq melanoma trial was stopped early this way when 1 treatment sequence proved clearly better.
Each trial lists who can join: cancer type and stage, prior treatments, tumor gene results, organ function, and other health conditions. Some trials accept only people who have not yet started treatment, so the best time to ask about trials is before each new treatment decision, including the first.
Trial costs fall into 2 groups. Routine patient care costs are the things you would need anyway, such as doctor visits, hospital stays, standard treatments, lab tests and scans. Research costs include the study drug and any extra tests done only for the study. The trial sponsor usually pays research costs.
Under the Affordable Care Act, most health plans must cover routine patient care costs for people in approved clinical trials, which include trials funded by federal agencies and those run under an FDA investigational new drug application. Medicare and Medicaid cover routine costs in qualifying trials too. Your usual deductibles and copays still apply.
Travel, lodging, parking, child care, and time off work are usually your own expense. Some trials help with these. Before you enroll, ask the study coordinator and the hospital's financial counselor for a written list of what you or your insurer will be billed.
Bring a short list to your oncologist, who may know which nearby studies are open.
